District Court, E.D. Pennsylvania July 24, 2020, 2:02-cv-02964 (UNITED STATES OF AMERICA ex rel. YOASH GOHIL v. AVENTIS PHARMACEUTICALS, INC.)
Also known as
United States · · · 24-07-2020
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
UNITED STATES ex rel. :
YOASH GOHIL, :
Plaintiff/Relator. : CIVIL ACTION
: No. 02-2964
v. :
:
SANOFI U.S. SERVICES INC. :
et al.,
Defendants. :
July 21, 2020 Anita B. Brody, J.
MEMORANDUM
Relator Yoash Gohil brings this lawsuit against Aventis, a large
pharmaceutical company and his former employer.1 Among other things, Gohil
alleges that Aventis violated the False Claims Act (“FCA”) by engaging in a
variety of nationwide kickback schemes between 1996-2004 to induce doctors to
prescribe—and then request government reimbursement for— Aventis’s cancer
drug, Taxotere. One of the alleged schemes involves Aventis’s reimbursement-
assistance program, the “Providing Access to Cancer Therapy Program”
1 As a result of several mergers, the Defendant has gone by several different names
throughout the relevant period of this lawsuit. For ease of reference, the Court
refers to Defendant solely as “Aventis.”
(“PACT”).2 PACT helped doctors submit reimbursement claims for Taxotere,
handled administrative appeals when those claims were denied, and gave doctors
free replacement vials of the drug when appeals were unsuccessful. Gohil
maintains that these services were kickbacks that led to the submission of “false or
fraudulent claims,” in violation of the False Claims Act.
In June and July of 2019, both parties filed cross-motions for summary
judgment focused on whether PACT’s services were illegal kickbacks that gave
rise to FCA liability. On March 4, 2020, I denied both motions. This
memorandum explains that denial.3
2 Throughout the relevant time period, Aventis hired third-party companies to
operate the PACT Program. In this opinion, references to “PACT” should be taken
to mean both Aventis and the companies it used to run PACT.
3 Gohil also alleges that Aventis entered into a variety of separate kickback
schemes to promote Taxotere, unrelated to the PACT Program.
Read the full text
This document is published by courtlistener.com.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit